Cholestasis

Gene: TMEM67

No list

TMEM67 (transmembrane protein 67)
EnsemblGeneIds (GRCh38): ENSG00000164953
EnsemblGeneIds (GRCh37): ENSG00000164953
OMIM: 609884, Gene2Phenotype
TMEM67 is in 26 panels

4 reviews

Zornitza Stark (Australian Genomics)

Red List (low evidence)

I agree, no specific association with cholestasis.
Created: 9 Aug 2020, 11:10 a.m. | Last Modified: 9 Aug 2020, 11:10 a.m.
Panel Version: 1.16

Miranda Durkie (Genetics)

Red List (low evidence)

Both genes (TMEM67 and RPGRIP1L) are associated with a range of severe, syndromic conditions, often presenting in utero, mainly affecting kidney, or other organs than liver, including Joubert type 6, Meckel type 3, Bardet Biedl syndrome, NPHP11, RHYNS and COACH syndrome. Both genes are covered elsewhere in the following panels that match the clinical presentations: Severe paediatric disorders R14, R27, Fetal anomalies R21, Intellectual disability R29, Retinal disorders R32, Structural eye disease R36, Bardet Biedl Syndrome R107, Cystic renal disease R193, Tubulointerstitial kidney disease R202, Unexplained paediatric onset ESRD R257. Neither gene-associated classical phenotype would have cholestasis as a presenting feature, and would very likely be referred to one or more of the above alternate panels. In COACH syndrome, the presentation is syndromic, the liver involvement includes congenital hepatic fibrosis (CHF). Therefore potentially they would fit better on polycystic liver disease panel as Caroli disease (PKHD1) is commonly associated with CHF; however the testing criteria for PCLD recommends R27 (as above) or R89 Ultra-rare and atypical monogenic disorders for any complex or syndromic presentations. There is just 1 reported case with isolated CHF with 2 TMEM67 variants in the literature (PMID: 28680603) although this is very weak as 1 variant is a VUS with no supporting functional data that could be erroneous. There are no reported cases with RPGRIP1L or CC2D2A and isolated CHF. The 3rd gene associated with COACH syndrome CC2D2A was green on the 100K neonatal cholestasis panel. However looking at the evidence for the CC2D2A gene it has 2 reviews on PanelApp and was scored as red by the Bham diagnostic service and scored green by a Genomics England curator. Therefore the evidence for inclusion of these 3 COACH genes in cholestasis is limited. COACH syndrome is extremely rare with an Orphanet estimated incidence of 1 in 1,000,000. There are 34 mutations on HGMD for TMEM67 associated with COACH syndrome and just 1 mutation for RPGRIP1L. I would like to request that these 3 genes are removed from the cholestasis panel on the next update.
Created: 18 May 2020, 10:44 a.m. | Last Modified: 18 May 2020, 10:44 a.m.
Panel Version: 1.4

Publications

Bill Griffiths (Cambridge University Hospitals)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
congenital hepatic fibrosis

Publications

Ivone Leong (Genomics England Curator)

Green List (high evidence)

Comment on list classification: This gene has been downgraded from Green to Grey based on expert review from Miranda Durkie (Genetics).
Created: 18 Aug 2020, 1:12 p.m. | Last Modified: 18 Aug 2020, 1:12 p.m.
Panel Version: 1.18
Comment on list classification: As discussed in the GMS Gastrohepatology Specialist Test Group webex call 14th Jan 2019: The Specialist Test Group agreed that there is enough evidence to rate this gene green. Promoted from amber to green.
Created: 28 Jan 2019, 1:58 p.m.
Comment when marking as ready: TMEM67 is a disease causing gene of Meckel syndrome and causes congenital hepatic malformations and fibrosis, which is a phenotype of ductal plate malformation.
Created: 26 Nov 2018, 2:25 p.m.
Comment on publications: There are >3 unrelated cases of variants in TMEM67 causing congenital hepatic malformations.
Created: 26 Nov 2018, 2:24 p.m.
TMEM67 also causes COACH syndrome (609884), which is considered by some to be a subtype of Joubert syndrome with congenital hepatic fibrosis, which is a phenotype of ductal plate malformation.
Created: 13 Nov 2018, 10:23 a.m.
Green gene on Rare ciliopathy panel. It is a confirmed gene for Meckel syndrome on Gene2Phenotype
Created: 12 Nov 2018, 1:55 p.m.

History Filter Activity

26 Feb 2021, Gel status: 0

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag curated_removed tag was added to gene: TMEM67.

18 Aug 2020, Gel status: 0

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: tmem67 has been removed from the panel.

18 Aug 2020, Gel status: 3

Removed Tag

Ivone Leong (Genomics England Curator)

Tag for-review was removed from gene: TMEM67.

18 May 2020, Gel status: 3

Added Tag

Ivone Leong (Genomics England Curator)

Tag for-review tag was added to gene: TMEM67.

28 Jan 2019, Gel status: 3

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: tmem67 has been classified as Green List (High Evidence).

28 Jan 2019, Gel status: 3

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: tmem67 has been classified as Green List (High Evidence).

24 Jan 2019, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Ivone Leong (Genomics England Curator)

gene: TMEM67 was added gene: TMEM67 was added to Cholestasis. Sources: NHS GMS Mode of inheritance for gene: TMEM67 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TMEM67 were set to 28680603; 16415887; 26191240; 19058225 Phenotypes for gene: TMEM67 were set to COACH syndrome (216360); {Bardet-Biedl syndrome 14, modifier of} (615991); Nephronophthisis 11 (613550); Meckel syndrome 3 (607361); Joubert syndrome 6 (310688); congenital hepatic fibrosis